Tag: postpartum

Ultimately, the FDA Advisory Committee recommended approval of brexanolone by a 17-1 member vote. I was the only NO vote. I voted NO because as the sole Consumer Representative on the committee I didn’t believe the company had demonstrated that the potential benefits outweighed the potential for harm.

Interpersonal therapy reduces the risk of postpartum depression in mothers on public assistance during first 6 months after giving birth.